SIA
DGX icon

SGL Investment Advisors’s Quest Diagnostics DGX Stock Holding History

SGL Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.36M Sell
28,258
-241
-0.8% -$46.8K 2.01% 19
2025
Q4 		$5.48M Buy
28,499
+450
+2% +$81.9K 2.19% 16
2025
Q3 		$5.02M Buy
28,049
+520
+2% +$92.3K 2.09% 16
2025
Q2 		$4.75M Buy
27,529
+814
+3% +$141K 2.26% 17
2025
Q1 		$4.7M Sell
26,715
-761
-3% -$125K 2.43% 12
2024
Q4 		$4.52M Buy
27,476
+906
+3% +$141K 2.28% 18
2024
Q3 		$4.17M Buy
+26,570
New +$3.97M 2.14% 18

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

SGL Investment Advisors's DGX Position: Q1 2026 in Review

SGL Investment Advisors reduced its Quest Diagnostics (DGX) stake by 0.85% in Q1 2026, selling an estimated $46.8K and leaving 28,258 shares worth $5.36M. The position accounts for 2.01% of the portfolio, ranked #19.

SGL Investment Advisors first reported a position in DGX in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.48M in Q4 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • SGL Investment Advisors held 28,258 shares of Quest Diagnostics worth $5.36M as of Q1 2026.
  • SGL Investment Advisors sold 241 Quest Diagnostics shares in Q1 2026, an estimated $46.8K.
  • Quest Diagnostics made up 2.01% of SGL Investment Advisors's portfolio in Q1 2026, its #19 holding.
  • SGL Investment Advisors first reported a position in Quest Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • SGL Investment Advisors's Quest Diagnostics position peaked at $5.48M in Q4 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.